SlideShare a Scribd company logo
1 of 27
BY:
SWATI SARIN
Federal Food, Drug, and Cosmetic Act
Acronym FFDCA, "FD&C Act"
Enacted by the 75th United States Congress
Citations
Public Law 75-717
Stat. 52 US Stat. 1040
Codification
U.S.C. sections created 21 U.S.C. § 301 et seq
Legislative history
• Signed into law by President Franklin D. Roosevelt on June 25, 1938
 18th & 19th Century:
• States in charge of domestic products & Federal authority limited to imports.
• Chemical preservatives, additives, and fraud became more common
• But-science’s ability to detect fraud was also advancing!
 Harvey W. Wiley (1844-1930)
• Published his 1st
paper on how to detect if “pure cane sugar” had been diluted
with glucose (1881).
• 1883 – Wiley became chief chemist in U.S. Department of Agriculture &
began investigating adulteration and misbranding of food products.
• Wiley’s “Poison Squad”- Experiments to test for effects of chemicals, food
preservatives on human body.
 1879 – 1906
Over 100 food and drug bills were put before Congress but none
of them passed.
 1906 – Public Outrage!!!
• Upton Sinclair’s “THE JUNGLE” published
which Exposed horrors of meat packing
industry.
 1906 – Pure Food and Drugs Act
• Prohibited the interstate transport of unlawful
(adulterated or misbranded) food and drugs
• Product labeling (not pre-market approval)
Labels on packaging could not be false or misleading
no requirement to disclose ingredient
11 “dangerous ingredients” could be used, but
had to be listed on label (e.g., alcohol, heroin, cocaine)
 1912
Harvey Wiley resigned & Created “Good Housekeeping Seal of Approval”
 1927
Bureau of Chemistry becomes the “Food, Drug, and Insecticide
Administration”
 1930
 Harvey Wiley died & Franklin Roosevelt elected president
 “Food, Drug, and Insecticide Administration” became the Food and Drug
Administration
 Consumer protection groups & journalists started pushing for a new and
improved law
The American Chamber of Horrors!!!
FDA assembled a traveling
road-show of horrible
products that were technically
“legal” under the old, 1906
law
1937 - Sulfanilamide crisis
 Tennessee company marketed an “Elixir Sulfanilamide” a
wonder drug for children
 Drug contains chemical analog of antifreeze, which contained
unlisted ingredient "diethylene glycol”
 kills >100 children
 Public outcry!!!
Failure to test for safety or to list ingredients was not a violation
of 1906 Act
Drug labels must include directions for safe use
Required pre-market approval for new drugs to ensure safety
Prohibited false therapeutic claims for drugs
Authorized factory inspections
FDA also given regulatory authority over medical devices (and
cosmetics) for the first time
Devices treated very similarly to drugs, except no pre-market
approval for devices
Federal Food,
Drug,
And Cosmetic Act
 Set of laws passed by Congress in 1938
 Gave authority to the U.S. Food and Drug Administration (FDA) to
oversee the safety of food, drugs, and cosmetics
 Principal author Royal S. Copeland, a three-term U.S. Senator from
New York.
 In 1968
 Electronic Product Radiation Control provisions were added to the FD&C
 Drug Efficacy Study Implementation (DESI) to incorporate into FD&C
regulations the recommendations from a National Academy of Sciences
investigation of effectiveness of previously marketed drugs
 The act has been amended many times, most recently to add requirements
about bioterrorism preparations.
Chapter One Short title
Chapter Two Definitions and terms
Chapter Three Prohibited Acts and Penalties, adulteration and
misbranding, enforcement through Justice Department
Chapter Four Authorizes the regulation of foods, standards of
Identity
Chapter Five Drugs and Devices
Chapter Six Cosmetics
Chapter Seven Administrative provisions and tools, Inspections
Chapter Eight Imports and Exports
Chapter Nine Miscellaneous
 201(f) is the definition for a food, which explicitly includes chewing gum
 201(g) is the definition for a drug
Drug is any substance that, when absorbed into the body of a living organism,
alters normal bodily function.
 201(h) is the definition for a medical device
Medical device is a product which is used for medical purposes in patients, in
diagnosis, therapy or surgery
 201(s) is the definition of a food additive
 201(ff) is the definition of a dietary supplement
Dietary supplement is a preparation intended to supplement the diet and
provide nutrients, such as vitamins, minerals, fiber, fatty acids, or amino
acids, that may be missing or may not be consumed in sufficient quantity in
a person's diet
This section contains both civil law and criminal law clauses.
Section Title FD&C Act Number U.S. Code Section Number
(21 U.S.C)
Chapter III (U.S.C. Subchapter
III)--Prohibited Acts and
Penalties
Prohibited Acts 301 331
Penalties 303 333
Seizure 304 334
Hearing Before Report of
Criminal Violation
305 335
Debarment, Temporary Denial of
Approval, and Suspension
306 335a
Civil Penalties 307 335b
Authority to Withdraw Approval
of Abbreviated Drug
Applications
308 335c
Report of Minor Violations 309 336
 There is a distinction in food adulteration between "good and
bad" those that are added and those that are naturally present.
Substances that are added are held to a stricter "may render (it)
injurious to health" standard, whereas substances that are
naturally present need only be at a level that "does not ordinarily
render it injurious to health”
Chapter Four:
Authorizes the regulation of foods, standards of
Identity
The Act made the certification of some food color additives mandatory.
 Some food colorings are generally recognized as safe (GRAS) by the FDA and do
not require certification.
The FDA lists nine FD&C (Food, Drugs & Cosmetics) certified color additives for
use in foods in the U.S, plus numerous D&C (Drugs & Cosmetics) colorings allowed
only in drugs for external application or cosmetics.
 Color additives derived from natural sources, such as vegetables, minerals or
animals, and man-made counterparts of natural derivatives, are exempt from
certification.
Both artificial and natural color additives are subject to rigorous standards of safety
before their approval for use in foods
Name Common name Color
FD&C Blue No. 1 Brilliant Blue FCF bright blue
FD&C Blue No. 2 Indigotine royal blue
FD&C Green No. 3 Fast Green FCF Seagreen
FD&C Red No. 3 Erythrosine cherry red
FD&C Red No. 40 Allura Red AC orange-red
FD&C Yellow No. 5 Tartrazine lemon yellow
FD&C Yellow No. 6 Sunset Yellow FCF Orange
Orange B
Citrus Red No.2
Food coloring & additives
Chapter IV (U.S.C. Subchapter
IV)--Food
FD&C Act Number U.S. Code Section Number
(21 U.S.C)
Definitions and Standards for
Food
401 341
Adulterated Food 402 342
Misbranded Food 403 343
Tolerances for Poisonous
Ingredients in Food
406 346
Food Additives 409 348
Bottled Drinking Water
Standards
410 349
Vitamins and Minerals 411 350
Requirements for Infant
Formulas
412 350a
New Dietary Ingredients 413 350b
Maintenance and Inspection of
Records
414 350c
Registration of Food Facilities 415 350d
Sanitary transportation practices 416 350e
 505 is the description of the drug approval process
 Class I: Devices that do not require premarket approval or clearance but
must follow general controls Eg; Dental floss
 510(k) is the section that allows for clearance of class II medical devices
 known as Premarket Notification(PMN)
 device manufacturers must register to notify FDA, at least 90 days in
advance, of their intent to market a medical device
Eg; Diagnostic tests, cardiac catheters, and amalgam alloys used to fill
cavities, hearing aids
 515 is the description of the class III device approval process.
 Devices that are approved by the Premarket Approval (PMA) process.
 These tend to be devices that are permanently implanted into a human body
or may be necessary to sustain life. Eg; artificial heart
 Cosmetics are products for "cleansing, beautifying, promoting
attractiveness, or altering the appearance."
 FD & C allows a manufacturer the ability to use ingredients or
raw materials and market the final product without government
approval.
 Chapter VI (U.S.C. 
Subchapter VI)—
Cosmetics
FD&C Act Number U.S. Code Section 
Number
(21 U.S.C)
Adulterated Cosmetics 601 361
Misbranded Cosmetics 602 362
Regulations Making
Exemptions
603 363
704 allows inspections of regulated entities.
Inspection results are reported on Form 483
Chapter Seven: Administrative provisions and tools,
Inspections
 Chapter VI (U.S.C. Subchapter 
VI)—Cosmetics
FD&C Act Number U.S. Code Section Number
(21 U.S.C)
Regulations and Hearings 701 371
Examinations and Investigations 702 372
Records of Interstate Shipment 703 373
Factory Inspection 704 374
Publicity 705 375
Seafood Inspection 706 376
Part 2 (U.S.C. Subpart 2)—Fees
Relating to Drugs
Part 3 (U.S.C. Subpart 3)—Fees
Relating to Devices
Part 4 (U.S.C. Subpart 4)—Fees
Relating to Animal Drugs
Chapter VIII (U.S.C.
Subchapter VIII)—
Imports and Exports
FD&C Act Number U.S. Code Section Number
(21 U.S.C)
Imports and Exports 801 381
Exports of Certain
Unapproved Products
802 382
Office of International
Relations
803 383
Importation of Prescription
Drugs
804 384
 Chapter IX (U.S.C. 
Subchapter IX)—
Miscellaneous
FD&C Act Number U.S. Code Section Number
(21 U.S.C)
Effective Date and Repeals 902 392
Food and Drug
Administration
903 393
Scientific Review Groups 904 394
Loan Repayment Program 905 395
Practice of Medicine 906 396
Contracts for Expert Review 907 396
Notices to States Regarding
Imported Food
908 398
Grants to States for
Inspections
909 399
 1951 - Food, Drug, and Cosmetics Act Amendments PL 82–215, 65 Stat
648.
o The Durham-Humphrey Amendment explicitly defined two specific categories
for medications, legend (prescription) and over-the-counter(OTC).
 1962 -Food, Drug, and Cosmetics Act Amendments, PL 87–781, 76 Stat
780.
 Kefauver Harris Amendment or "Drug Efficacy Amendment“
 In response to Thalidomide tragedy
 Introduced a requirement for drug manufacturers to provide proof of the
effectiveness and safety of their drugs before approval
 required drug advertising to disclose accurate information about side effects
 stopped cheap generic drugs being marketed as expensive drugs under new trade
names as new "breakthrough" medications.
 Fair Packaging and Labeling Act, PL 89–755, 80 Stat 1296.
 It requires the label to state: identity of the product; name and place of business of
the manufacturer, packer, or distributor; and net quantity of contents in both metric
and U.S. customary units.
 Medical Device Regulation Act, PL 94–295, 90 Stat 539,.
 Radiation Control for Safety and Health Act, PL 90-602, 82 Stat 1173.
 (Jan. 4, 1983) - Orphan Drug Act, PL 97-414.
• Companies that develop such a drug (a drug for a disorder affecting fewer than
200,000 people in the United States) may sell it without competition for seven
years, and may get clinical trial tax incentives
 1984 -Drug Price Competition and Patent Term Restoration Act , PL 98-
471, 98 Stat 1585.
 known as the "Hatch-Waxman Act"
 established the modern system of generic drugs.
 amended the Federal FD & C Act Section 505(j) 21 U.S.C. 355(j) sets forth the
process by which would-be marketers of generic drugs can file Abbreviated New
Drug Applications (ANDAs) to seek FDA approval of the generic.
 1990 -Nutrition Labelling and Education Act, PL 101-535, 104 Stat 2353
• Gives the FDA authority to require nutrition labeling of most foods regulated by the
Agency.
 1990 -Safe Medical Device Amendments, PL 101-629, 104 Stat 4511.
 Food and Drug Administration Revitalization Act, PL 101-635, 104 Stat
4583.
 1994 -Dietary Supplement Health and Education Act, PL 103-417, 108 Stat
4332
• defined a product that is intended to supplement the diet and contains any of the
following dietary ingredients: a vitamin; a mineral; an herb or other
botanical(excluding tobacco); an amino acid; a concentrate, metabolite, constituent,
extract, or combination of any of the above to be labelled as “dietary supplement”.
 1997 -Food and Drug Administration Modernization Act, PL 105-115, 111
Stat 2296
• Amended FFDCA relating to the regulation of food, drugs, devices, and biological
products by the FDA.
• It was signed by Bill Clinton on 21 November 1997, and was fully enacted by 1
April 1999
• One result of the passing of the act was a reduction in the time for the approval of
new pharmaceutical drugs
 2007 -Food and Drug Administration Amendments Act, PL 110-85, 121
Stat 823
• Signed on September 27, 2007 by President George W. Bush
• This new law is an important step for the FDA.
• It reviewed, expanded, and reaffirmed several existing pieces of legislation
regulating the FDA
• Prescription Drug User Fee Act- was first enacted in 1992 to allow the FDA to
collect “user fees” from biotechnology and pharmaceutical companies.
• It has been reauthorized three times; first in 1997, then 2002, and most recently with
the passage of the FDAAA in 2007.
• Medical Device User Fee and Modernization Act (MDUFMA)
• Best Pharmaceuticals for Children Act (BPCA)
• Pediatric Research Equity Act (PREA)
• Priority Review to Encourage Treatments for Tropical Diseases
• Reagan-Udall foundation- created to “modernize medical, veterinary, food, food
ingredient, and cosmetic product development, accelerate innovation, and enhance
product safety.”
• Clinical trials reporting- on the freely-accessible site ClinicalTrials.gov
http://www.fda.gov/regulatoryinformation/legislation
/federalfooddrugandcosmeticactfdcact
http://en.wikipedia.org/wiki/Federal_Food,_Drug,_an
d_Cosmetic_Act
uwacadweb.uwyo.edu
QUESTIONS????QUESTIONS????
Food drug and cosmetic act 1938

More Related Content

What's hot

regulatory approval process of drug, cosmetic and herbals in canada
regulatory approval process of drug, cosmetic and herbals  in canada regulatory approval process of drug, cosmetic and herbals  in canada
regulatory approval process of drug, cosmetic and herbals in canada Richa Patel
 
Abriviated new drug application 505(j) filling
Abriviated new drug application 505(j) fillingAbriviated new drug application 505(j) filling
Abriviated new drug application 505(j) fillingshahnawazQuadir
 
Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationShoba Elangovan
 
REGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptxREGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptxAartiVats5
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inJAYA PRAKASH VELUCHURI
 
regulatory aspects of medical devices in USA
regulatory aspects of medical devices in USAregulatory aspects of medical devices in USA
regulatory aspects of medical devices in USAnavyasribandaru
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Aakashdeep Raval
 
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...sandeep bansal
 
Usa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augstUsa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augstRanjiniDM
 
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptxCLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptxFaizanShaikh204666
 
Quality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in IndiaQuality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in IndiaS S N D Balakrishna Ch
 
Regulation Governing Clinical Trials In India,USA and Europe.
Regulation Governing Clinical Trials In India,USA and Europe.  Regulation Governing Clinical Trials In India,USA and Europe.
Regulation Governing Clinical Trials In India,USA and Europe. KapilKumar198
 
Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India RichaTrivedi16
 
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsLabeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsMichael Swit
 
labelling requirements and label claims for dietary supplements in USA
labelling requirements and label claims for dietary supplements in USAlabelling requirements and label claims for dietary supplements in USA
labelling requirements and label claims for dietary supplements in USAnavyasribandaru
 
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...Akshay Anand
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japanManish kumar
 
plasma master file in European countries and requirements in letter of intent...
plasma master file in European countries and requirements in letter of intent...plasma master file in European countries and requirements in letter of intent...
plasma master file in European countries and requirements in letter of intent...Sanjay batra
 

What's hot (20)

regulatory approval process of drug, cosmetic and herbals in canada
regulatory approval process of drug, cosmetic and herbals  in canada regulatory approval process of drug, cosmetic and herbals  in canada
regulatory approval process of drug, cosmetic and herbals in canada
 
Abriviated new drug application 505(j) filling
Abriviated new drug application 505(j) fillingAbriviated new drug application 505(j) filling
Abriviated new drug application 505(j) filling
 
Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluation
 
REGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptxREGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptx
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics in
 
GHTF
GHTFGHTF
GHTF
 
regulatory aspects of medical devices in USA
regulatory aspects of medical devices in USAregulatory aspects of medical devices in USA
regulatory aspects of medical devices in USA
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.
 
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
 
Usa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augstUsa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augst
 
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptxCLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
 
Quality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in IndiaQuality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in India
 
GHTF study group 3
GHTF study group 3GHTF study group 3
GHTF study group 3
 
Regulation Governing Clinical Trials In India,USA and Europe.
Regulation Governing Clinical Trials In India,USA and Europe.  Regulation Governing Clinical Trials In India,USA and Europe.
Regulation Governing Clinical Trials In India,USA and Europe.
 
Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India
 
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsLabeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
 
labelling requirements and label claims for dietary supplements in USA
labelling requirements and label claims for dietary supplements in USAlabelling requirements and label claims for dietary supplements in USA
labelling requirements and label claims for dietary supplements in USA
 
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japan
 
plasma master file in European countries and requirements in letter of intent...
plasma master file in European countries and requirements in letter of intent...plasma master file in European countries and requirements in letter of intent...
plasma master file in European countries and requirements in letter of intent...
 

Viewers also liked

Drugs & cosmetics act 1940
Drugs & cosmetics act 1940Drugs & cosmetics act 1940
Drugs & cosmetics act 1940Rakshit Thumar
 
Historical aspects of drug approval process
Historical aspects of drug approval processHistorical aspects of drug approval process
Historical aspects of drug approval processparesh bharodiya
 
Chapter 3 drug regulation and control
Chapter 3 drug regulation and controlChapter 3 drug regulation and control
Chapter 3 drug regulation and controlAnn Bentley
 
drug and cosmetic act 1940
drug and cosmetic act 1940drug and cosmetic act 1940
drug and cosmetic act 1940Nahim Saife
 
List of Impurities 231015
List of Impurities 231015List of Impurities 231015
List of Impurities 231015Sitec Labs
 
Marketing Authorization procedures in developed and developing countries
Marketing Authorization procedures in developed and developing countriesMarketing Authorization procedures in developed and developing countries
Marketing Authorization procedures in developed and developing countriesAkshay Saxena
 
Marketing Authorization In The Eu
Marketing Authorization In The EuMarketing Authorization In The Eu
Marketing Authorization In The Euclarityeye
 
SOP For Product Recall
SOP For Product RecallSOP For Product Recall
SOP For Product Recallmuna_ali
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairssekhara
 
Regulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & IndiaRegulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & IndiaDr. Pankaj Bablani
 
Regulatory affairs-Introduction to CTD
Regulatory affairs-Introduction to CTDRegulatory affairs-Introduction to CTD
Regulatory affairs-Introduction to CTDMahesh shinde
 
Drug and cosmetic act
Drug and cosmetic actDrug and cosmetic act
Drug and cosmetic actrahulrabbit
 
Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...
Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...
Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...Atlantic Training, LLC.
 
6 Presentation Styles of Famous Presenters
6 Presentation Styles of Famous Presenters6 Presentation Styles of Famous Presenters
6 Presentation Styles of Famous Presenters24Slides
 

Viewers also liked (20)

The drug and cosmetic act and rules
The drug and cosmetic act and rulesThe drug and cosmetic act and rules
The drug and cosmetic act and rules
 
Drugs & cosmetics act 1940
Drugs & cosmetics act 1940Drugs & cosmetics act 1940
Drugs & cosmetics act 1940
 
Historical aspects of drug approval process
Historical aspects of drug approval processHistorical aspects of drug approval process
Historical aspects of drug approval process
 
Chapter 3 drug regulation and control
Chapter 3 drug regulation and controlChapter 3 drug regulation and control
Chapter 3 drug regulation and control
 
Product recall overview
Product recall overviewProduct recall overview
Product recall overview
 
drug and cosmetic act 1940
drug and cosmetic act 1940drug and cosmetic act 1940
drug and cosmetic act 1940
 
List of Impurities 231015
List of Impurities 231015List of Impurities 231015
List of Impurities 231015
 
Marketing Authorization procedures in developed and developing countries
Marketing Authorization procedures in developed and developing countriesMarketing Authorization procedures in developed and developing countries
Marketing Authorization procedures in developed and developing countries
 
Marketing Authorization In The Eu
Marketing Authorization In The EuMarketing Authorization In The Eu
Marketing Authorization In The Eu
 
SOP For Product Recall
SOP For Product RecallSOP For Product Recall
SOP For Product Recall
 
Orange book
Orange bookOrange book
Orange book
 
Drug approval process
Drug approval processDrug approval process
Drug approval process
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
Regulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & IndiaRegulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & India
 
Regulatory affairs-Introduction to CTD
Regulatory affairs-Introduction to CTDRegulatory affairs-Introduction to CTD
Regulatory affairs-Introduction to CTD
 
Drug and cosmetic act
Drug and cosmetic actDrug and cosmetic act
Drug and cosmetic act
 
Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...
Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...
Implementation of GMP’s for Cosmetics in a Changing Global Environment Traini...
 
D & c act
D & c actD & c act
D & c act
 
6 Presentation Styles of Famous Presenters
6 Presentation Styles of Famous Presenters6 Presentation Styles of Famous Presenters
6 Presentation Styles of Famous Presenters
 
Pre Clinical Studies
Pre Clinical StudiesPre Clinical Studies
Pre Clinical Studies
 

Similar to Food drug and cosmetic act 1938

Food and Drugs Administration.pptx
Food and Drugs Administration.pptxFood and Drugs Administration.pptx
Food and Drugs Administration.pptxAnkitsharma811886
 
73What is Special Education 1iStockphotoThinkstock.docx
73What is Special Education 1iStockphotoThinkstock.docx73What is Special Education 1iStockphotoThinkstock.docx
73What is Special Education 1iStockphotoThinkstock.docxalinainglis
 
Drug Use, Regulation, and the LawChapter 3Guid.docx
Drug Use, Regulation, and the LawChapter 3Guid.docxDrug Use, Regulation, and the LawChapter 3Guid.docx
Drug Use, Regulation, and the LawChapter 3Guid.docxjacksnathalie
 
CHAPTER 23 Consumer ProtectionRestaurantFederal and state go.docx
CHAPTER 23 Consumer ProtectionRestaurantFederal and state go.docxCHAPTER 23 Consumer ProtectionRestaurantFederal and state go.docx
CHAPTER 23 Consumer ProtectionRestaurantFederal and state go.docxtiffanyd4
 
Introduction to the Legal Basis for Generic Drug Approvals
Introduction to the Legal Basis for Generic Drug ApprovalsIntroduction to the Legal Basis for Generic Drug Approvals
Introduction to the Legal Basis for Generic Drug ApprovalsMichael Swit
 
Drug development and nda
Drug development and ndaDrug development and nda
Drug development and ndaGaurav Kr
 
Drug and Cosmetic Act 1940 and Rules 1945
Drug and Cosmetic Act 1940 and Rules 1945Drug and Cosmetic Act 1940 and Rules 1945
Drug and Cosmetic Act 1940 and Rules 1945Dr. Ambekar Abdul Wahid
 
US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.Venugopal N
 
USFDA GUIDLINES
USFDA GUIDLINESUSFDA GUIDLINES
USFDA GUIDLINESRaj Tiwari
 
Analyzing the Dietary Supplement Health and Education Act and other related r...
Analyzing the Dietary Supplement Health and Education Act and other related r...Analyzing the Dietary Supplement Health and Education Act and other related r...
Analyzing the Dietary Supplement Health and Education Act and other related r...AJHSSR Journal
 
Drug development and regulation
Drug development and regulationDrug development and regulation
Drug development and regulationraj kumar
 
Drug development and regulation
Drug development and regulationDrug development and regulation
Drug development and regulationraj kumar
 

Similar to Food drug and cosmetic act 1938 (20)

Food and Drugs Administration.pptx
Food and Drugs Administration.pptxFood and Drugs Administration.pptx
Food and Drugs Administration.pptx
 
usfda-160428060046.pdf
usfda-160428060046.pdfusfda-160428060046.pdf
usfda-160428060046.pdf
 
usfda-160428060046.pdf
usfda-160428060046.pdfusfda-160428060046.pdf
usfda-160428060046.pdf
 
USFDA
USFDAUSFDA
USFDA
 
73What is Special Education 1iStockphotoThinkstock.docx
73What is Special Education 1iStockphotoThinkstock.docx73What is Special Education 1iStockphotoThinkstock.docx
73What is Special Education 1iStockphotoThinkstock.docx
 
Overview of the FDA
Overview of the FDAOverview of the FDA
Overview of the FDA
 
Laws n drugs
Laws n drugsLaws n drugs
Laws n drugs
 
Drug Use, Regulation, and the LawChapter 3Guid.docx
Drug Use, Regulation, and the LawChapter 3Guid.docxDrug Use, Regulation, and the LawChapter 3Guid.docx
Drug Use, Regulation, and the LawChapter 3Guid.docx
 
FDA
FDAFDA
FDA
 
CHAPTER 23 Consumer ProtectionRestaurantFederal and state go.docx
CHAPTER 23 Consumer ProtectionRestaurantFederal and state go.docxCHAPTER 23 Consumer ProtectionRestaurantFederal and state go.docx
CHAPTER 23 Consumer ProtectionRestaurantFederal and state go.docx
 
Introduction to the Legal Basis for Generic Drug Approvals
Introduction to the Legal Basis for Generic Drug ApprovalsIntroduction to the Legal Basis for Generic Drug Approvals
Introduction to the Legal Basis for Generic Drug Approvals
 
Drug development and nda
Drug development and ndaDrug development and nda
Drug development and nda
 
Drug and Cosmetic Act 1940 and Rules 1945
Drug and Cosmetic Act 1940 and Rules 1945Drug and Cosmetic Act 1940 and Rules 1945
Drug and Cosmetic Act 1940 and Rules 1945
 
US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.
 
History & Evolution of GMP Regulations
History & Evolution of GMP RegulationsHistory & Evolution of GMP Regulations
History & Evolution of GMP Regulations
 
1 gmp essentials
1 gmp essentials1 gmp essentials
1 gmp essentials
 
USFDA GUIDLINES
USFDA GUIDLINESUSFDA GUIDLINES
USFDA GUIDLINES
 
Analyzing the Dietary Supplement Health and Education Act and other related r...
Analyzing the Dietary Supplement Health and Education Act and other related r...Analyzing the Dietary Supplement Health and Education Act and other related r...
Analyzing the Dietary Supplement Health and Education Act and other related r...
 
Drug development and regulation
Drug development and regulationDrug development and regulation
Drug development and regulation
 
Drug development and regulation
Drug development and regulationDrug development and regulation
Drug development and regulation
 

More from swati2084

Who expert committee recommendations for pharmaceutical products
Who expert committee recommendations for pharmaceutical productsWho expert committee recommendations for pharmaceutical products
Who expert committee recommendations for pharmaceutical productsswati2084
 
Patient recruitment
Patient recruitmentPatient recruitment
Patient recruitmentswati2084
 
Multicenter trial
Multicenter trialMulticenter trial
Multicenter trialswati2084
 
Methods of patient recruitment
Methods of patient recruitmentMethods of patient recruitment
Methods of patient recruitmentswati2084
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and ndaswati2084
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drugswati2084
 
HIV and TB coinfection
HIV and TB coinfectionHIV and TB coinfection
HIV and TB coinfectionswati2084
 
Animal toxicology studies
Animal toxicology studiesAnimal toxicology studies
Animal toxicology studiesswati2084
 

More from swati2084 (8)

Who expert committee recommendations for pharmaceutical products
Who expert committee recommendations for pharmaceutical productsWho expert committee recommendations for pharmaceutical products
Who expert committee recommendations for pharmaceutical products
 
Patient recruitment
Patient recruitmentPatient recruitment
Patient recruitment
 
Multicenter trial
Multicenter trialMulticenter trial
Multicenter trial
 
Methods of patient recruitment
Methods of patient recruitmentMethods of patient recruitment
Methods of patient recruitment
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and nda
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drug
 
HIV and TB coinfection
HIV and TB coinfectionHIV and TB coinfection
HIV and TB coinfection
 
Animal toxicology studies
Animal toxicology studiesAnimal toxicology studies
Animal toxicology studies
 

Recently uploaded

Keppel Ltd. 1Q 2024 Business Update Presentation Slides
Keppel Ltd. 1Q 2024 Business Update  Presentation SlidesKeppel Ltd. 1Q 2024 Business Update  Presentation Slides
Keppel Ltd. 1Q 2024 Business Update Presentation SlidesKeppelCorporation
 
Call Girls In Panjim North Goa 9971646499 Genuine Service
Call Girls In Panjim North Goa 9971646499 Genuine ServiceCall Girls In Panjim North Goa 9971646499 Genuine Service
Call Girls In Panjim North Goa 9971646499 Genuine Serviceritikaroy0888
 
Lucknow 💋 Escorts in Lucknow - 450+ Call Girl Cash Payment 8923113531 Neha Th...
Lucknow 💋 Escorts in Lucknow - 450+ Call Girl Cash Payment 8923113531 Neha Th...Lucknow 💋 Escorts in Lucknow - 450+ Call Girl Cash Payment 8923113531 Neha Th...
Lucknow 💋 Escorts in Lucknow - 450+ Call Girl Cash Payment 8923113531 Neha Th...anilsa9823
 
Mysore Call Girls 8617370543 WhatsApp Number 24x7 Best Services
Mysore Call Girls 8617370543 WhatsApp Number 24x7 Best ServicesMysore Call Girls 8617370543 WhatsApp Number 24x7 Best Services
Mysore Call Girls 8617370543 WhatsApp Number 24x7 Best ServicesDipal Arora
 
HONOR Veterans Event Keynote by Michael Hawkins
HONOR Veterans Event Keynote by Michael HawkinsHONOR Veterans Event Keynote by Michael Hawkins
HONOR Veterans Event Keynote by Michael HawkinsMichael W. Hawkins
 
Monte Carlo simulation : Simulation using MCSM
Monte Carlo simulation : Simulation using MCSMMonte Carlo simulation : Simulation using MCSM
Monte Carlo simulation : Simulation using MCSMRavindra Nath Shukla
 
The Coffee Bean & Tea Leaf(CBTL), Business strategy case study
The Coffee Bean & Tea Leaf(CBTL), Business strategy case studyThe Coffee Bean & Tea Leaf(CBTL), Business strategy case study
The Coffee Bean & Tea Leaf(CBTL), Business strategy case studyEthan lee
 
Tech Startup Growth Hacking 101 - Basics on Growth Marketing
Tech Startup Growth Hacking 101  - Basics on Growth MarketingTech Startup Growth Hacking 101  - Basics on Growth Marketing
Tech Startup Growth Hacking 101 - Basics on Growth MarketingShawn Pang
 
Value Proposition canvas- Customer needs and pains
Value Proposition canvas- Customer needs and painsValue Proposition canvas- Customer needs and pains
Value Proposition canvas- Customer needs and painsP&CO
 
VIP Kolkata Call Girl Howrah 👉 8250192130 Available With Room
VIP Kolkata Call Girl Howrah 👉 8250192130  Available With RoomVIP Kolkata Call Girl Howrah 👉 8250192130  Available With Room
VIP Kolkata Call Girl Howrah 👉 8250192130 Available With Roomdivyansh0kumar0
 
Pharma Works Profile of Karan Communications
Pharma Works Profile of Karan CommunicationsPharma Works Profile of Karan Communications
Pharma Works Profile of Karan Communicationskarancommunications
 
It will be International Nurses' Day on 12 May
It will be International Nurses' Day on 12 MayIt will be International Nurses' Day on 12 May
It will be International Nurses' Day on 12 MayNZSG
 
Progress Report - Oracle Database Analyst Summit
Progress  Report - Oracle Database Analyst SummitProgress  Report - Oracle Database Analyst Summit
Progress Report - Oracle Database Analyst SummitHolger Mueller
 
9599632723 Top Call Girls in Delhi at your Door Step Available 24x7 Delhi
9599632723 Top Call Girls in Delhi at your Door Step Available 24x7 Delhi9599632723 Top Call Girls in Delhi at your Door Step Available 24x7 Delhi
9599632723 Top Call Girls in Delhi at your Door Step Available 24x7 DelhiCall Girls in Delhi
 
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRLMONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRLSeo
 
Ensure the security of your HCL environment by applying the Zero Trust princi...
Ensure the security of your HCL environment by applying the Zero Trust princi...Ensure the security of your HCL environment by applying the Zero Trust princi...
Ensure the security of your HCL environment by applying the Zero Trust princi...Roland Driesen
 
Grateful 7 speech thanking everyone that has helped.pdf
Grateful 7 speech thanking everyone that has helped.pdfGrateful 7 speech thanking everyone that has helped.pdf
Grateful 7 speech thanking everyone that has helped.pdfPaul Menig
 
Monthly Social Media Update April 2024 pptx.pptx
Monthly Social Media Update April 2024 pptx.pptxMonthly Social Media Update April 2024 pptx.pptx
Monthly Social Media Update April 2024 pptx.pptxAndy Lambert
 
Event mailer assignment progress report .pdf
Event mailer assignment progress report .pdfEvent mailer assignment progress report .pdf
Event mailer assignment progress report .pdftbatkhuu1
 
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...Dave Litwiller
 

Recently uploaded (20)

Keppel Ltd. 1Q 2024 Business Update Presentation Slides
Keppel Ltd. 1Q 2024 Business Update  Presentation SlidesKeppel Ltd. 1Q 2024 Business Update  Presentation Slides
Keppel Ltd. 1Q 2024 Business Update Presentation Slides
 
Call Girls In Panjim North Goa 9971646499 Genuine Service
Call Girls In Panjim North Goa 9971646499 Genuine ServiceCall Girls In Panjim North Goa 9971646499 Genuine Service
Call Girls In Panjim North Goa 9971646499 Genuine Service
 
Lucknow 💋 Escorts in Lucknow - 450+ Call Girl Cash Payment 8923113531 Neha Th...
Lucknow 💋 Escorts in Lucknow - 450+ Call Girl Cash Payment 8923113531 Neha Th...Lucknow 💋 Escorts in Lucknow - 450+ Call Girl Cash Payment 8923113531 Neha Th...
Lucknow 💋 Escorts in Lucknow - 450+ Call Girl Cash Payment 8923113531 Neha Th...
 
Mysore Call Girls 8617370543 WhatsApp Number 24x7 Best Services
Mysore Call Girls 8617370543 WhatsApp Number 24x7 Best ServicesMysore Call Girls 8617370543 WhatsApp Number 24x7 Best Services
Mysore Call Girls 8617370543 WhatsApp Number 24x7 Best Services
 
HONOR Veterans Event Keynote by Michael Hawkins
HONOR Veterans Event Keynote by Michael HawkinsHONOR Veterans Event Keynote by Michael Hawkins
HONOR Veterans Event Keynote by Michael Hawkins
 
Monte Carlo simulation : Simulation using MCSM
Monte Carlo simulation : Simulation using MCSMMonte Carlo simulation : Simulation using MCSM
Monte Carlo simulation : Simulation using MCSM
 
The Coffee Bean & Tea Leaf(CBTL), Business strategy case study
The Coffee Bean & Tea Leaf(CBTL), Business strategy case studyThe Coffee Bean & Tea Leaf(CBTL), Business strategy case study
The Coffee Bean & Tea Leaf(CBTL), Business strategy case study
 
Tech Startup Growth Hacking 101 - Basics on Growth Marketing
Tech Startup Growth Hacking 101  - Basics on Growth MarketingTech Startup Growth Hacking 101  - Basics on Growth Marketing
Tech Startup Growth Hacking 101 - Basics on Growth Marketing
 
Value Proposition canvas- Customer needs and pains
Value Proposition canvas- Customer needs and painsValue Proposition canvas- Customer needs and pains
Value Proposition canvas- Customer needs and pains
 
VIP Kolkata Call Girl Howrah 👉 8250192130 Available With Room
VIP Kolkata Call Girl Howrah 👉 8250192130  Available With RoomVIP Kolkata Call Girl Howrah 👉 8250192130  Available With Room
VIP Kolkata Call Girl Howrah 👉 8250192130 Available With Room
 
Pharma Works Profile of Karan Communications
Pharma Works Profile of Karan CommunicationsPharma Works Profile of Karan Communications
Pharma Works Profile of Karan Communications
 
It will be International Nurses' Day on 12 May
It will be International Nurses' Day on 12 MayIt will be International Nurses' Day on 12 May
It will be International Nurses' Day on 12 May
 
Progress Report - Oracle Database Analyst Summit
Progress  Report - Oracle Database Analyst SummitProgress  Report - Oracle Database Analyst Summit
Progress Report - Oracle Database Analyst Summit
 
9599632723 Top Call Girls in Delhi at your Door Step Available 24x7 Delhi
9599632723 Top Call Girls in Delhi at your Door Step Available 24x7 Delhi9599632723 Top Call Girls in Delhi at your Door Step Available 24x7 Delhi
9599632723 Top Call Girls in Delhi at your Door Step Available 24x7 Delhi
 
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRLMONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
MONA 98765-12871 CALL GIRLS IN LUDHIANA LUDHIANA CALL GIRL
 
Ensure the security of your HCL environment by applying the Zero Trust princi...
Ensure the security of your HCL environment by applying the Zero Trust princi...Ensure the security of your HCL environment by applying the Zero Trust princi...
Ensure the security of your HCL environment by applying the Zero Trust princi...
 
Grateful 7 speech thanking everyone that has helped.pdf
Grateful 7 speech thanking everyone that has helped.pdfGrateful 7 speech thanking everyone that has helped.pdf
Grateful 7 speech thanking everyone that has helped.pdf
 
Monthly Social Media Update April 2024 pptx.pptx
Monthly Social Media Update April 2024 pptx.pptxMonthly Social Media Update April 2024 pptx.pptx
Monthly Social Media Update April 2024 pptx.pptx
 
Event mailer assignment progress report .pdf
Event mailer assignment progress report .pdfEvent mailer assignment progress report .pdf
Event mailer assignment progress report .pdf
 
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
Enhancing and Restoring Safety & Quality Cultures - Dave Litwiller - May 2024...
 

Food drug and cosmetic act 1938

  • 2. Federal Food, Drug, and Cosmetic Act Acronym FFDCA, "FD&C Act" Enacted by the 75th United States Congress Citations Public Law 75-717 Stat. 52 US Stat. 1040 Codification U.S.C. sections created 21 U.S.C. § 301 et seq Legislative history • Signed into law by President Franklin D. Roosevelt on June 25, 1938
  • 3.  18th & 19th Century: • States in charge of domestic products & Federal authority limited to imports. • Chemical preservatives, additives, and fraud became more common • But-science’s ability to detect fraud was also advancing!  Harvey W. Wiley (1844-1930) • Published his 1st paper on how to detect if “pure cane sugar” had been diluted with glucose (1881). • 1883 – Wiley became chief chemist in U.S. Department of Agriculture & began investigating adulteration and misbranding of food products. • Wiley’s “Poison Squad”- Experiments to test for effects of chemicals, food preservatives on human body.  1879 – 1906 Over 100 food and drug bills were put before Congress but none of them passed.
  • 4.  1906 – Public Outrage!!! • Upton Sinclair’s “THE JUNGLE” published which Exposed horrors of meat packing industry.  1906 – Pure Food and Drugs Act • Prohibited the interstate transport of unlawful (adulterated or misbranded) food and drugs • Product labeling (not pre-market approval) Labels on packaging could not be false or misleading no requirement to disclose ingredient 11 “dangerous ingredients” could be used, but had to be listed on label (e.g., alcohol, heroin, cocaine)
  • 5.  1912 Harvey Wiley resigned & Created “Good Housekeeping Seal of Approval”  1927 Bureau of Chemistry becomes the “Food, Drug, and Insecticide Administration”  1930  Harvey Wiley died & Franklin Roosevelt elected president  “Food, Drug, and Insecticide Administration” became the Food and Drug Administration  Consumer protection groups & journalists started pushing for a new and improved law The American Chamber of Horrors!!! FDA assembled a traveling road-show of horrible products that were technically “legal” under the old, 1906 law
  • 6. 1937 - Sulfanilamide crisis  Tennessee company marketed an “Elixir Sulfanilamide” a wonder drug for children  Drug contains chemical analog of antifreeze, which contained unlisted ingredient "diethylene glycol”  kills >100 children  Public outcry!!! Failure to test for safety or to list ingredients was not a violation of 1906 Act
  • 7. Drug labels must include directions for safe use Required pre-market approval for new drugs to ensure safety Prohibited false therapeutic claims for drugs Authorized factory inspections FDA also given regulatory authority over medical devices (and cosmetics) for the first time Devices treated very similarly to drugs, except no pre-market approval for devices Federal Food, Drug, And Cosmetic Act
  • 8.  Set of laws passed by Congress in 1938  Gave authority to the U.S. Food and Drug Administration (FDA) to oversee the safety of food, drugs, and cosmetics  Principal author Royal S. Copeland, a three-term U.S. Senator from New York.  In 1968  Electronic Product Radiation Control provisions were added to the FD&C  Drug Efficacy Study Implementation (DESI) to incorporate into FD&C regulations the recommendations from a National Academy of Sciences investigation of effectiveness of previously marketed drugs  The act has been amended many times, most recently to add requirements about bioterrorism preparations.
  • 9. Chapter One Short title Chapter Two Definitions and terms Chapter Three Prohibited Acts and Penalties, adulteration and misbranding, enforcement through Justice Department Chapter Four Authorizes the regulation of foods, standards of Identity Chapter Five Drugs and Devices Chapter Six Cosmetics Chapter Seven Administrative provisions and tools, Inspections Chapter Eight Imports and Exports Chapter Nine Miscellaneous
  • 10.  201(f) is the definition for a food, which explicitly includes chewing gum  201(g) is the definition for a drug Drug is any substance that, when absorbed into the body of a living organism, alters normal bodily function.  201(h) is the definition for a medical device Medical device is a product which is used for medical purposes in patients, in diagnosis, therapy or surgery  201(s) is the definition of a food additive  201(ff) is the definition of a dietary supplement Dietary supplement is a preparation intended to supplement the diet and provide nutrients, such as vitamins, minerals, fiber, fatty acids, or amino acids, that may be missing or may not be consumed in sufficient quantity in a person's diet
  • 11. This section contains both civil law and criminal law clauses. Section Title FD&C Act Number U.S. Code Section Number (21 U.S.C) Chapter III (U.S.C. Subchapter III)--Prohibited Acts and Penalties Prohibited Acts 301 331 Penalties 303 333 Seizure 304 334 Hearing Before Report of Criminal Violation 305 335 Debarment, Temporary Denial of Approval, and Suspension 306 335a Civil Penalties 307 335b Authority to Withdraw Approval of Abbreviated Drug Applications 308 335c Report of Minor Violations 309 336
  • 12.  There is a distinction in food adulteration between "good and bad" those that are added and those that are naturally present. Substances that are added are held to a stricter "may render (it) injurious to health" standard, whereas substances that are naturally present need only be at a level that "does not ordinarily render it injurious to health” Chapter Four: Authorizes the regulation of foods, standards of Identity
  • 13. The Act made the certification of some food color additives mandatory.  Some food colorings are generally recognized as safe (GRAS) by the FDA and do not require certification. The FDA lists nine FD&C (Food, Drugs & Cosmetics) certified color additives for use in foods in the U.S, plus numerous D&C (Drugs & Cosmetics) colorings allowed only in drugs for external application or cosmetics.  Color additives derived from natural sources, such as vegetables, minerals or animals, and man-made counterparts of natural derivatives, are exempt from certification. Both artificial and natural color additives are subject to rigorous standards of safety before their approval for use in foods Name Common name Color FD&C Blue No. 1 Brilliant Blue FCF bright blue FD&C Blue No. 2 Indigotine royal blue FD&C Green No. 3 Fast Green FCF Seagreen FD&C Red No. 3 Erythrosine cherry red FD&C Red No. 40 Allura Red AC orange-red FD&C Yellow No. 5 Tartrazine lemon yellow FD&C Yellow No. 6 Sunset Yellow FCF Orange Orange B Citrus Red No.2 Food coloring & additives
  • 14. Chapter IV (U.S.C. Subchapter IV)--Food FD&C Act Number U.S. Code Section Number (21 U.S.C) Definitions and Standards for Food 401 341 Adulterated Food 402 342 Misbranded Food 403 343 Tolerances for Poisonous Ingredients in Food 406 346 Food Additives 409 348 Bottled Drinking Water Standards 410 349 Vitamins and Minerals 411 350 Requirements for Infant Formulas 412 350a New Dietary Ingredients 413 350b Maintenance and Inspection of Records 414 350c Registration of Food Facilities 415 350d Sanitary transportation practices 416 350e
  • 15.  505 is the description of the drug approval process  Class I: Devices that do not require premarket approval or clearance but must follow general controls Eg; Dental floss  510(k) is the section that allows for clearance of class II medical devices  known as Premarket Notification(PMN)  device manufacturers must register to notify FDA, at least 90 days in advance, of their intent to market a medical device Eg; Diagnostic tests, cardiac catheters, and amalgam alloys used to fill cavities, hearing aids  515 is the description of the class III device approval process.  Devices that are approved by the Premarket Approval (PMA) process.  These tend to be devices that are permanently implanted into a human body or may be necessary to sustain life. Eg; artificial heart
  • 16.  Cosmetics are products for "cleansing, beautifying, promoting attractiveness, or altering the appearance."  FD & C allows a manufacturer the ability to use ingredients or raw materials and market the final product without government approval.  Chapter VI (U.S.C.  Subchapter VI)— Cosmetics FD&C Act Number U.S. Code Section  Number (21 U.S.C) Adulterated Cosmetics 601 361 Misbranded Cosmetics 602 362 Regulations Making Exemptions 603 363
  • 17. 704 allows inspections of regulated entities. Inspection results are reported on Form 483 Chapter Seven: Administrative provisions and tools, Inspections  Chapter VI (U.S.C. Subchapter  VI)—Cosmetics FD&C Act Number U.S. Code Section Number (21 U.S.C) Regulations and Hearings 701 371 Examinations and Investigations 702 372 Records of Interstate Shipment 703 373 Factory Inspection 704 374 Publicity 705 375 Seafood Inspection 706 376 Part 2 (U.S.C. Subpart 2)—Fees Relating to Drugs Part 3 (U.S.C. Subpart 3)—Fees Relating to Devices Part 4 (U.S.C. Subpart 4)—Fees Relating to Animal Drugs
  • 18. Chapter VIII (U.S.C. Subchapter VIII)— Imports and Exports FD&C Act Number U.S. Code Section Number (21 U.S.C) Imports and Exports 801 381 Exports of Certain Unapproved Products 802 382 Office of International Relations 803 383 Importation of Prescription Drugs 804 384
  • 19.  Chapter IX (U.S.C.  Subchapter IX)— Miscellaneous FD&C Act Number U.S. Code Section Number (21 U.S.C) Effective Date and Repeals 902 392 Food and Drug Administration 903 393 Scientific Review Groups 904 394 Loan Repayment Program 905 395 Practice of Medicine 906 396 Contracts for Expert Review 907 396 Notices to States Regarding Imported Food 908 398 Grants to States for Inspections 909 399
  • 20.  1951 - Food, Drug, and Cosmetics Act Amendments PL 82–215, 65 Stat 648. o The Durham-Humphrey Amendment explicitly defined two specific categories for medications, legend (prescription) and over-the-counter(OTC).  1962 -Food, Drug, and Cosmetics Act Amendments, PL 87–781, 76 Stat 780.  Kefauver Harris Amendment or "Drug Efficacy Amendment“  In response to Thalidomide tragedy  Introduced a requirement for drug manufacturers to provide proof of the effectiveness and safety of their drugs before approval  required drug advertising to disclose accurate information about side effects  stopped cheap generic drugs being marketed as expensive drugs under new trade names as new "breakthrough" medications.  Fair Packaging and Labeling Act, PL 89–755, 80 Stat 1296.  It requires the label to state: identity of the product; name and place of business of the manufacturer, packer, or distributor; and net quantity of contents in both metric and U.S. customary units.
  • 21.  Medical Device Regulation Act, PL 94–295, 90 Stat 539,.  Radiation Control for Safety and Health Act, PL 90-602, 82 Stat 1173.  (Jan. 4, 1983) - Orphan Drug Act, PL 97-414. • Companies that develop such a drug (a drug for a disorder affecting fewer than 200,000 people in the United States) may sell it without competition for seven years, and may get clinical trial tax incentives  1984 -Drug Price Competition and Patent Term Restoration Act , PL 98- 471, 98 Stat 1585.  known as the "Hatch-Waxman Act"  established the modern system of generic drugs.  amended the Federal FD & C Act Section 505(j) 21 U.S.C. 355(j) sets forth the process by which would-be marketers of generic drugs can file Abbreviated New Drug Applications (ANDAs) to seek FDA approval of the generic.
  • 22.  1990 -Nutrition Labelling and Education Act, PL 101-535, 104 Stat 2353 • Gives the FDA authority to require nutrition labeling of most foods regulated by the Agency.  1990 -Safe Medical Device Amendments, PL 101-629, 104 Stat 4511.  Food and Drug Administration Revitalization Act, PL 101-635, 104 Stat 4583.  1994 -Dietary Supplement Health and Education Act, PL 103-417, 108 Stat 4332 • defined a product that is intended to supplement the diet and contains any of the following dietary ingredients: a vitamin; a mineral; an herb or other botanical(excluding tobacco); an amino acid; a concentrate, metabolite, constituent, extract, or combination of any of the above to be labelled as “dietary supplement”.
  • 23.  1997 -Food and Drug Administration Modernization Act, PL 105-115, 111 Stat 2296 • Amended FFDCA relating to the regulation of food, drugs, devices, and biological products by the FDA. • It was signed by Bill Clinton on 21 November 1997, and was fully enacted by 1 April 1999 • One result of the passing of the act was a reduction in the time for the approval of new pharmaceutical drugs
  • 24.  2007 -Food and Drug Administration Amendments Act, PL 110-85, 121 Stat 823 • Signed on September 27, 2007 by President George W. Bush • This new law is an important step for the FDA. • It reviewed, expanded, and reaffirmed several existing pieces of legislation regulating the FDA • Prescription Drug User Fee Act- was first enacted in 1992 to allow the FDA to collect “user fees” from biotechnology and pharmaceutical companies. • It has been reauthorized three times; first in 1997, then 2002, and most recently with the passage of the FDAAA in 2007. • Medical Device User Fee and Modernization Act (MDUFMA) • Best Pharmaceuticals for Children Act (BPCA) • Pediatric Research Equity Act (PREA) • Priority Review to Encourage Treatments for Tropical Diseases • Reagan-Udall foundation- created to “modernize medical, veterinary, food, food ingredient, and cosmetic product development, accelerate innovation, and enhance product safety.” • Clinical trials reporting- on the freely-accessible site ClinicalTrials.gov